申请人:Eli Lilly and Company
公开号:US20140005222A1
公开(公告)日:2014-01-02
The present invention provides a compound of the Formula II:
wherein A is:
R
1
is CH
3
, CF
3
, or F;
R
2
is H, CH
3
, or F;
R
3
is CH
3
, OCH
3
, OH, F;
R
4
is OH or CH
2
OH; and
X is CH or N;
or a pharmaceutically acceptable salt thereof.
本发明提供了式II的化合物:其中A是:R1为CH3,CF3或F;R2为H,CH3或F;R3为CH3,OCH3,OH,F;R4为OH或CH2OH;X为CH或N;或其药学上可接受的盐。